Papers/PMID:40485009
Treatment of Hypovitaminosis D With Cholecalciferol in Dogs With Protein-Losing Enteropathies: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial.
Journal of veterinary internal medicine2025The record
1 finding · 1 compound · 1 endpoint
What it reported
How to read these marksWhat moved
1 finding
calciol — increases serum 25-hydroxyvitamin D concentration
PreliminaryGrade D, Preliminary. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×10“Dogs with PLE treated with cholecalciferol had higher 25OHD concentrations at T2 compared to dogs treated with placebo (225 nmol/L, range 72-434 vs. 80 nmol/L, range 31-254 nmol/L; p = 0.004).”
Quoted verbatim from Treatment of Hypovitaminosis D With Cholecalciferol in Dogs With Protein-Losing Enteropathies: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial.. - Study
- animal · not in humans
- Duration
- 4 weeks
- Dose
- 400 IU/kg cholecalciferol PO daily for 6 weeks
- Population
- dogs with protein-losing enteropathy and decreased serum 25OHD, receiving standard PLE therapy in both arms
Treatment of Hypovitaminosis D With Cholecalciferol in Dogs With Protein-Losing Enteropathies: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial.2025PMID:40485009Permalink